DarioHealth reports Q1 EPS ($1.25), consensus (85c)
Summary
DarioHealth reported Q1 earnings per share of ($1.25), missing the analyst consensus of $0.85. The brief note appears in The Fly / DRIO dashboard financial summary for the company. The piece focuses on the company’s quarterly financial performance rather than hires, fundraising, M&A, or product announcements. The EPS shortfall is a clear miss versus expectations and reflects a negative surprise in the company’s reported results.
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
No AI classifications detected